Infectious disease companies develop technologies, diagnostics and therapeutics that prevent, detect and treat bacterial, viral, fungal and parasitic infections. Their work supports global health, outbreak response and disease surveillance.
This category includes companies working on:
Browse 118 UK infectious disease companies below.
Global biopharma with UK manufacturing, commercial and clinical operations
MSD is a global biopharmaceutical company discovering, developing, manufacturing and marketing medicines and vaccines across oncology, infectious disease, immunology, cardiometabolic disease and animal health. Its UK operations span pharmaceutical manufacturing at Cramlington, Northumberland, which supplies medicines…
Global pharma company in immunology, vaccines, and oncology
GSK is a multinational biopharmaceutical company engaged in the research, development, manufacture, and commercialisation of medicines and vaccines. Its pipeline and portfolio span respiratory and immunology, oncology, HIV (through its specialist subsidiary ViiV Healthcare), and infectious diseases including vaccines.…
Clinical-stage antifungal drug developer targeting invasive fungal infections
F2G is a clinical-stage biopharmaceutical company developing novel antifungal therapies for life-threatening invasive fungal infections. The company discovered the orotomides, a new class of antifungal agents that selectively inhibit fungal dihydroorotate dehydrogenase, a mechanism of action distinct from all approved…
High-sensitivity lateral flow diagnostics for point-of-care testing
SwiftDx is a Cambridge-based diagnostics company developing a next generation of high-sensitivity lateral flow assays using proprietary eAMP (enhanced Amplification) and DNA detection technologies. Its platform enables detection of targets undetectable by conventional lateral flow tests, without requiring specialist…
Electrochemical lateral flow diagnostics for accessible at-home health testing
éclateral is a UK-based developer of electrochemical lateral flow diagnostic technology for at-home and point-of-care testing. The company's portable reader pairs with adapted lateral flow test cassettes and a companion mobile app to deliver quantitative, sensitive results beyond standard optical lateral flow…
Multiplex qPCR and NGS kits for molecular detection
YouSeq is a UK manufacturer of multiplex Next Generation Sequencing and qPCR kits, panels and reagents. The company offers one of the largest menus of qPCR targets available, covering human infectious diseases, antimicrobial resistance profiling, food and water safety, microbiome analysis, and veterinary diagnostics.…
Infectious disease antigens and antibodies for diagnostics and research
The Native Antigen Company is a manufacturer of native and recombinant antigens, antibodies, and immunoassays for viral and bacterial infectious disease targets. Products are supplied to IVD manufacturers, pharmaceutical companies, and academic institutions for use in immunoassay development, serology, vaccine…
Human biospecimen and disease-state plasma supplier
Logical Biological is a UK supplier of human biological materials including disease-state and normal-donor serum, plasma, swabs, tissues, PBMCs, and biofluids to IVD manufacturers and life science researchers worldwide. The company sources specimens through a global network of donor centres and blood banks across five…
AI-powered portable diagnostics platform for field-based disease testing
Vidiia is a diagnostics company developing AI-powered, portable molecular testing devices for point-of-care and field-based disease detection. Its platform combines RT-LAMP assay chemistry with smartphone-connected artificial intelligence to interpret results, and has received UK regulatory approval for medical use.…
In vitro diagnostic reagents, test kits and analysers for clinical laboratories
Fortress Diagnostics is a Northern Ireland-based manufacturer of in vitro diagnostic products, supplying clinical chemistry reagents, immunoassays, haematology reagents, haemostasis consumables, serology test kits, quality controls and calibrators, and diagnostic instrumentation to hospitals, blood banks, and research…
BBSRC-funded national institute for animal biosciences research
The Roslin Institute is a BBSRC-funded national institute for animal biosciences research, part of the University of Edinburgh's Royal (Dick) School of Veterinary Studies. Research is organised around three challenge areas: sustainable farmed animal production, infectious disease detection and prevention, and…
UK manufacturer of bespoke autogenous vaccines for farm animals and fish
Ridgeway Biologicals is a UK manufacturer of bespoke veterinary vaccines prepared from pathogens extracted directly from an affected farm to control disease outbreaks in that specific animal group. Licensed by the Veterinary Medicines Directorate, the company serves the pig, poultry, ruminant and aquaculture sectors,…
Pathogen genomic surveillance tools and antimicrobial resistance research
Centre for Genomic Pathogen Surveillance is a University of Oxford research centre developing genomic epidemiology methods and tools for infectious disease surveillance. Its Pathogenwatch and Microreact platforms support pathogen genome analysis, antimicrobial resistance prediction, strain clustering and visualisation…
Infectious disease drug development and partnering organisation
Infex Therapeutics is a clinical-stage drug development company focused on antimicrobial resistance and pandemic-priority infectious diseases, based at Alderley Park. Founded as The AMR Centre in 2016, the company acquires and co-develops novel therapeutics through in-licensing and risk-sharing partnerships with…
Bacterial-like particle vaccine platform targeting recurrent UTIs
Spectre Bio is a biotechnology company developing a non-antibiotic prophylactic vaccine for recurrent UTIs, a major unmet medical need and significant driver of antimicrobial resistance. The company's platform produces programmable, non-replicative bacterial cells that retain a full native antigen profile while being…
Monoclonal antibodies for viral infectious disease
RQ Biotechnology is a passive immunisation company discovering and developing long-acting monoclonal antibodies to provide immediate protection against viral infections in immunocompromised and vulnerable populations. Founded by members of the UK COVID-19 Antibody Taskforce and co-founded with LifeArc, the company's…
Virus-like particle vaccine platform for infectious disease and diagnostics
iQur is a London-based biotechnology company developing vaccines using its proprietary tandem core virus-like particle platform. The technology uses the hepatitis B virus core protein to display multiple antigens simultaneously, stimulating strong immune responses without the risks of live or attenuated viruses.…
European specialty pharma focused on gastroenterology and hepatology
Norgine is a European specialty pharmaceutical company developing, manufacturing, and commercialising medicines across gastroenterology, hepatology, and cancer supportive care. Founded in 1906 and privately owned, the company markets a portfolio of specialty pharmaceutical products and medical devices across Europe,…
Next-generation lipid nanoparticle platform for RNA vaccines and medicines
NeoVac is a biotechnology company developing a next-generation lipid nanoparticle platform to improve the delivery of RNA vaccines and therapeutics. Its library of fully biodegradable, tissue-targeted LNPs addresses limitations of first-generation formulations, offering enhanced thermostability, multiple routes of…
qPCR assays and reagents for infectious disease and pathogen detection
Primerdesign is a Manchester-based molecular diagnostics company designing, manufacturing, and supplying real-time qPCR assays and reagents for pathogen detection across human health, animal health, food safety, and environmental monitoring. Its catalogue of over 400 CE-IVD and research-use-only detection kits covers…